The nation of Zimbabwe has turned down a substantial US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years over the United States' insistence on sensitive information.
This rejection was revealed after a official document from December was leaked, which showed Head of State Emmerson Mnangagwa felt the arrangement was "lopsided".
An official representative has since stated that the US was requesting biological samples for research and commercial purposes while was unwilling to guarantee the resulting advantages from future medical innovations.
"We are forced to start the challenging and unfortunate task of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has urged more talks to secure a deal acceptable to all parties so the country's vital HIV programme can continue.
Wider Implications
This development comes after a comparable case in Kenya, where a court suspended a related deal with the US after concerns were filed about the safety of Kenyans' health data.
Since returning to office last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump stated its spending was "inefficient" and his government was seeking direct bilateral agreements to boost openness and responsibility.
Based on reports, Sixteen African countries have so far agreed to similar health pacts, constituting more than $18.3bn of fresh investment.
Specifics of the Rejected Agreement
The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership could have provided immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently on antiretroviral therapy through American-funded initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"The proposal required Zimbabwe to surrender its biological resources and data for a long time, without any equivalent assurance of benefiting from any medical innovations – like new medicines or tests – that could result from that shared data," his statement read.
"In essence, our country would supply the basic resources for medical research with no assurance that the end products would be accessible to our citizens if a new disease outbreak arise."
National Interest and International Frameworks
He also noted that the American exit from the global health body and its push of bilateral deals were disrupting frameworks already set up through the global organization.
The spokesperson cited its Pandemic Benefit-Sharing framework created to manage potential pandemics.
"This mechanism is intended to ensure that when a nation contributes its information, the benefits – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to develop them."
The government's concerns over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We welcome further dialogue with our US partners on how subsequent collaboration might be structured in a way that respects the sovereignty and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but recommended that talks need to persist considering a large portion of the country's Aids initiatives relied on external financing.
"If specific concerns exist, such as those relating to information security or agreement terms, these can often be addressed through technical clarification and mutually agreed protections," it added.
The halted deal underscores the complex debate between accepting vital international aid and protecting a country's data in an increasingly interconnected world.